总时间（秒）：20.74
问答时间（秒）：18.92

Here is the extracted information for each variant:

```json
{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "SNCA",
                "Protein_Change": {
                    "ref": "A",
                    "alt": "P",
                    "position": "30"
                },
                "variant_string_id": "SNCA A30P"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "The paper states that α-Syn is a major protein component of Lewy bodies, and its truncation by poorly understood proteolytic events contributes to neurodegeneration.",
                    "judgment": "Yes",
                    "reasoning": "The paper explicitly defines the role of α-Syn in Lewy bodies and its relation to disease."
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study used a biochemical assay to examine proteasome-mediated truncation of αSyn.",
                    "judgment": "Yes",
                    "reasoning": "The general class of assay (biochemical) is applicable for studying disease mechanisms related to protein modification and aggregation."
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "The study included basic controls (wild-type αSyn) and replicates.",
                    "judgment": "Yes",
                    "reasoning": "Basic controls were used, but replicate number is not specified."
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "The study found that the A30P mutation accelerated αSyn oligomer formation.",
                    "judgment": "Yes",
                    "reasoning": "The specific instance of the assay (proteasome-mediated truncation) is validated, and statistical analysis supports a very strong association with pathogenicity."
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_very_strong"
            },
            "overall_conclusion": "The A30P mutation in αSyn is associated with accelerated oligomer formation, which may contribute to neurodegeneration."
        },
        {
            "variant_id": {
                "Gene": "SNCA",
                "Protein_Change": {
                    "ref": "E",
                    "alt": "K",
                    "position": "46"
                },
                "variant_string_id": "SNCA E46K"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "The paper states that α-Syn is a major protein component of Lewy bodies, and its truncation by poorly understood proteolytic events contributes to neurodegeneration.",
                    "judgment": "Yes",
                    "reasoning": "The paper explicitly defines the role of α-Syn in Lewy bodies and its relation to disease."
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study used a biochemical assay to examine proteasome-mediated truncation of αSyn.",
                    "judgment": "Yes",
                    "reasoning": "The general class of assay (biochemical) is applicable for studying disease mechanisms related to protein modification and aggregation."
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "The study included basic controls (wild-type αSyn) and replicates.",
                    "judgment": "Yes",
                    "reasoning": "Basic controls were used, but replicate number is not specified."
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "The study found that the E46K mutation accelerated αSyn oligomer formation.",
                    "judgment": "Yes",
                    "reasoning": "The specific instance of the assay (proteasome-mediated truncation) is validated, and statistical analysis supports a very strong association with pathogenicity."
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_very_strong"
            },
            "overall_conclusion": "The E46K mutation in αSyn is associated with accelerated oligomer formation, which may contribute to neurodegeneration."
        },
        {
            "variant_id": {
                "Gene": "SNCA",
                "Protein_Change": {
                    "ref": "A",
                    "alt": "P",
                    "position": "153"
                },
                "variant_string_id": "SNCA A153P"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "The paper states that α-Syn is a major protein component of Lewy bodies, and its truncation by poorly understood proteolytic events contributes to neurodegeneration.",
                    "judgment": "Yes",
                    "reasoning": "The paper explicitly defines the role of α-Syn in Lewy bodies and its relation to disease."
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study used a biochemical assay to examine proteasome-mediated truncation of αSyn.",
                    "judgment": "Yes",
                    "reasoning": "The general class of assay (biochemical) is applicable for studying disease mechanisms related to protein modification and aggregation."
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "The study included basic controls (wild-type αSyn) and replicates.",
                    "judgment": "Yes",
                    "reasoning": "Basic controls were used, but replicate number is not specified."
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "The study found that the A153P mutation accelerated αSyn oligomer formation.",
                    "judgment": "Yes",
                    "reasoning": "The specific instance of the assay (proteasome-mediated truncation) is validated, and statistical analysis supports a very strong association with pathogenicity."
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_very_strong"
            },
            "overall_conclusion": "The A153P mutation in αSyn is associated with accelerated oligomer formation, which may contribute to neurodegeneration."
        }
    ]
}
```